Martin E Gutierrez, MD

Martin E. Gutierrez, MD is Professor of Medicine at the Hackensack Meridian School of Medicine and serves as Director of the Phase I/Experimental Therapeutics Program and Chief of Thoracic Oncology at Hackensack Meridian John Theurer Cancer Center. He is an internationally recognized medical oncologist specializing in thoracic malignancies, early-phase clinical trials, immunotherapy, targeted therapies, and precision oncology.

Dr. Gutierrez has dedicated his career to accelerating the development of novel cancer therapies through innovative clinical research. He is a recognized leader in national and international early drug development and has served as principal investigator on numerous first-in-human and first-in-class clinical trials. His work has contributed to the clinical development and regulatory approval of multiple anticancer therapies, bringing promising new treatments to patients worldwide. Under his leadership, the Phase I Program at John Theurer Cancer Center has become one of the largest and most active early-phase oncology programs in the New York–New Jersey region and a destination for innovative cancer clinical trials.

Before joining Hackensack Meridian Health, Dr. Gutierrez held leadership positions at the National Cancer Institute, where he led thoracic oncology clinical research and served as Associate Director of the Medical Oncology Fellowship Program. He has authored more than 200 peer-reviewed publications and over 100 scientific abstracts presented at leading international meetings. His work has been cited more than 12,000 times, reflecting his significant contributions to the advancement of cancer therapeutics.

In addition to his clinical and research leadership, Dr. Gutierrez is committed to mentoring the next generation of physician-scientists and expanding access to cutting-edge clinical trials through integrated cancer networks. His vision is to establish a nationally recognized model for early drug development that accelerates scientific discovery while delivering innovative therapies to patients closer to home.

Frequently Asked Questions (FAQs)

1. What is a medical oncologist?
A medical oncologist is a cancer doctor who treats cancer using medicine, such as chemotherapy, immunotherapy, and targeted therapies.

2. Are clinical trials safe?
Clinical trials have risks, but patient safety is our number one priority. Every trial follows a very strict plan that is approved and monitored by experts to make sure patients are as safe as possible.

3. What is immunotherapy?
Immunotherapy is a type of treatment that helps your own immune system find and attack cancer cells.

4. What is targeted therapy?
Targeted therapy is a type of cancer drug that is designed to attack a specific part of a cancer cell, which can be more effective and have different side effects than traditional chemotherapy.

5. How can I schedule an appointment with Dr. Gutierrez?
You can schedule an appointment with Dr. Gutierrez online or by calling one of his offices.

• HMH John Theurer Cancer Center Oncology Hackensack
  92 2nd Street
  551-996-5855

• John Theurer Cancer Center at Jersey Shore University Medical Center
  19 Davis Avenue
  833-226-2376